B型脑钠肽与不同病因心力衰竭的研究进展

www.yongyao.net　　2009-9-25 11:58:58　　来源：　　责任编辑：

分享到：

[ 参考文献]
[ 1 ] 　Dasgup ta A, Chow L, Tso G, et al. Stability of NT2p roBNP in serum specimens collected in Becton Dickinson Vacutainer ( SST) tubes[ J ]. Clin Chem, 2003, 49(6pt) : 958.
[ 2 ] 　Yandle TG. B iochemistry of natriuretic pep tides[ J ]. J IntMed, 1994, 235 (6) :561.
[ 3 ] 　Nakagawa O,Ogawa Y, Itoh H, et al. Evidence for brain natriuretic pep tide as an“emergency”cardiac hormone against ventricular overload [ J ]. J Clin Invest,1995, 96 (3) : 1280.
[ 4 ] 　CowieMR,Mendez GF. BNP and congestive heart failure [ J ]. Prog CardiovascDis, 2002, 44 (4) : 293.
[ 5 ] 　Yeo KT,Wu AH,App le FS, et al. Multicenter evaluation of the RocheNT2NP assay and comparison to the B iosite Triage BNP assay[ J ]. Clin Chim Acta, 2003,338: 107-115.
[ 6 ] 　Lubien E,DeMaria A, Krishnaswamy P, et al. U tility of B2natriuretic pep tide in detecting diastolic dysfunction: comparison with Dopp ler velocity recordings[ J ].Circulation, 2002, 105 (5) : 595 601.
[ 7 ] 　朱红俊,龚少愚,邹　逊,等. 心力衰竭病因对血浆BNP水平的影响[ J ]. 临床荟萃, 2007, 22 (1) : 27228.
[ 8 ] 　杨海波,唐元升,朱兴雷,等. 早期再灌注对急性心肌梗死患者血浆脑钠素水平的影响[ J ]. 临床心血管病杂志, 2004, 20 (7) : 401.
[ 9 ] 　Nilsson JC, Groenning BA, Nielsen Q, et al. Left ventricular remodeling in the first year after acute myocardial infarction and the p redictive value ofN2terminalp robrain natriuretic pep tide[ J ]. Am Heart J , 2002, 143 (4) : 676.
[ 10 ] 　Magga J , PuhakkaM, Hietakorp i S, et al. Atrial natriuretic pep tide, 82 type natriuretic pep tide and serum collagen markers after acute myocardial infarction[ J ]. J App l Phsiol, 2004, 96 (4) : 1306.
[ 11 ] 　SuzukiN,Mor H, Hazam AM, et al. Relationship between brain natriuretic peptide and coronary stenosis: influence of aging[ J ]. J Cardiol, 2004, 43 (3) : 117-122.
[ 12 ] 　吕先光,刘朝中. B2型利尿钠肽在冠心病所致慢性充血性心力衰竭的诊断、治疗和愈后评估中的作用[ J ]. 现代生物医学进展, 2007, 7 ( 6) : 930-933
[ 13 ] 　Olsson LG, Swedberg K, Cleland JGF, et al. Prognostic importance of p lasmaNT2p roBNP in chronic heart failure in patients treated with aβ2blocker: results from the CarvedilolOrMetop rolol European Trial (COMET) trial [ J ]. Eur JHeart Fail, 2007, 9 (8) : 795-801.
[ 14 ] 　SuzukiM, Yamamoto K,Watanabe S, et al. Association between elevated brain natriuretic pep tide levels and development of left ventricular hypertrophy in patientswith hypertension[ J ]. Am J Med, 2000, 108 (8) : 627-633.
[ 15 ] 　KaragiannisA, Tziomalos K, Zamboulis C. Plasma B2type natriuretic pep tide is related to left ventricularmass in hypertensive patients [ J ]. Eur Heart J , 2004,25 (21) : 1967.
[ 16 ] 　KohnoM,MinamiM, Kano H, et al. Effect of angiotensin converting enzyme inhibitor on left ventricular parameters and circulating brain natriuretic pep tide in elderly hypertensiveswith left ventricular hypertrophy [ J ]. Metabolism, 2000,49 (10) : 1356-1360.
[ 17 ] 　宋浩明,邓　兵,沈　艺,等. 高血压病患者脑钠肽水平与心脏测量指标的相关性[ J ]. 心脏杂志, 2007, 19 (1) : 85286.
[ 18 ] 　MasazumiW,MikikoM, Hitoshi F. Ismeasurement of p lasma brain natriureticpep tide levels a useful test to detect for surgical timing of valve disease [ J ] Int J Cardiol, 2004, 96 (1) : 21-24.
[ 19 ] 　向　阳,吴贻全,王锦凤. 血浆脑钠肽在甲亢性心脏病诊断中的意义[ J ].临床与实验医学杂志, 2007, 6 (5) : 21-23.
[ 20 ] 　重组人脑利钠肽临床研究协作组. 重组人脑利钠肽和硝酸甘油治疗急性失代偿性心力衰竭疗效和安全性的随机、开放、平行对照的多中心临床研究[ J ]. 中华心血管病杂志, 2006, 34: 222-226.
[ 21 ] 　Wfrank P IV, Charles LE, James Y. Nesiritide in congestive heart failure associated with acute coronary syndromes: a p ilot study of safety and efficacy[ J ]. JCard Fail, 2004, 10: 120-125.
[ 22 ] 　Andrew D. Effects of intravenous nesiritide on human coronary vasomotor regulation and myocardial oxygen up take[ J ]. Circulation, 2003, 107: 2697-2701.
[ 23 ] 　Yancy CW, SaltzbergMT,Berkowitz RL, et al. Safety and feasibility of using serial infusions of nesiritide for heart failure in an outpatient setting ( from theFUSION I trail) [ J ]. Am J Cardiol, 2004, 95 (5) : 595-601.